-
News | 2023.11.15
The Institut Pasteur pays tribute to Dr. Grancher, physician and “Pasteurian”
On November 7, 2023, the Grancher Foundation celebrated its 120th anniversary on the Institut Pasteur campus. The Foundation was established by Dr. Joseph Grancher. It was an opportunity for the Institut Pasteur's President to pay tribute to the physician best known for his work on tuberculosis – a disease that the Institut Pasteur continues to fight.
-
News | 2023.02.20
Two effective new antiviral drugs for SARS-CoV-2
Scientists at the Institut Pasteur have successfully synthesized two novel molecules that are active against several variants of the virus responsible for COVID-19. The discovery could inspire new families of antiviral drugs against future emerging viral diseases.
-
News | 2022.09.01
Malaria: blood stage of the parasite recreated in vivo to help tackle the disease
By engrafting human hematopoietic stem cells into mice, a team from the Institut Pasteur, Inserm and the CNRS was able to maintain the Plasmodium vivax parasite in vivo, providing a novel model to explore therapeutic strategies.
-
News | 2017.06.29
Viral hepatitis: the challenge of communication in Africa
WHO adopted in 2016 a global strategy to eliminate hepatitis B and C by 2030. On the basis of anthropological analyses conducted in multiple African countries, a group of researchers, including some from the Institut Pasteur, suggest that to achieve these goals it is essential to improve the communication about viral hepatitis. According to WHO, viral hepatitis caused 1.34 million deaths in...
-
Article | 2019.05.21
Emerging infectious diseases
Ever since its very early days, the Institut Pasteur has been committed to tackling emerging infections, and its work has left an extraordinary legacy. Many emerging infectious diseases are zoonoses, in which an animal pathogen has crossed the species barrier to cause disease in humans.
-
Document de presse | 2021.05.28
COVID-19: analysis of the sensitivity of the Delta variant to monoclonal antibodies and sera from convalescent and vaccinated individuals
The Delta variant was detected for the first time in India in October 2020 and has since spread throughout the world. It is now dominant in many countries and regions (India, the UK, Portugal, Russia, etc.) and is predicted to be the most prevalent variant in Europe within weeks or months. Epidemiological studies have shown that the Delta variant is more transmissible than other variants....
-
Article | 2020.03.27
Coronavirus (Covid-19) research projects
VACCINE CANDIDATES1. Development of an animal model and accelerated development of a DNA vaccine candidate(SCARD SARS-CoV-2 project)Aims:To develop a mouse model of SARS-CoV-2 infection.This will not only enable us to evaluate the efficacy of the vaccine; it will also facilitate in vivo research on SARS-CoV-2. To evaluate the immunogenicity (ability to induce a specific immune reaction) and...
-
Fiche maladie | 2015.10.06
Viral hepatitis
Hepatitis is an inflammation of the liver caused by toxic substances or – in the majority of cases – by viruses. To date, five viruses have been identified that target the liver and cause inflammatory infection. These viruses are referred to by the letters A, B, C, D and E, and vary according to their transmission mode (fecal-oral for A and E, parenteral for B and C) and their aggressive profile.
-
Fiche maladie | 2017.04.24
Antibiotic resistance
Antibiotics are drugs used to treat infections caused by bacteria. Antibiotic resistance occurs when bacteria become resistant and no longer respond to these drugs.
-
Document de presse | 2016.06.23
Antibodies that are effective against both dengue and Zika viruses
Scientists from the Institut Pasteur and the CNRS[1], in collaboration with Imperial College London and the University of Vienna, Austria, have identified antibodies that can efficiently neutralize both the dengue virus and the Zika virus. The description of the binding site for these antibodies on the viral envelope, identical for both viruses, could lead to the development of a universal...